Many published reviews have suggested that circulating fetuin-A may play a role in the risk of type 2 diabetes mellitus, cardiovascular disease, and nonalcoholic fatty liver disease [18, 19]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.